Role of Interferon in the Augmented Resistance of Trehalose-6,6'-dimycolate-treated Mice to Influenza Virus Infection
- 1 March 1987
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 68 (3) , 835-843
- https://doi.org/10.1099/0022-1317-68-3-835
Abstract
Summary Mice inoculated intravenously with 10 to 100 µg trehalose-6,6′-dimycolate in an oil-in-water emulsion (TDM emulsion) acquired high resistance to intranasal infection by influenza virus at 7 to 14 days, but not at 1 day, after treatment. Mice inoculated with an oil-in-water emulsion without TDM (control emulsion) did not resist infection. The activity of the reticuloendothelial system of mice inoculated with TDM emulsion or control emulsion was greatly stimulated 1 day and 14 days after treatment. Interferon production in response to influenza virus was augmented in lung and serum of TDM emulsion-treated mice. The augmented interferon production was greatly diminished in the TDM emulsion-treated mice by treatment with anti-Thy-1.2 monoclonal antibody. Production of haemagglutination-inhibiting antibody in the TDM emulsion-treated or control emulsion-treated mice was higher than that in untreated mice, although no difference was observed between the TDM emulsion-treated and control emulsion-treated mice. On the other hand, TDM emulsion treatment of mice did not influence the appearance of antibody-producing cells, nor the activity of natural killer cells in the mice. The enhanced resistance of mice was diminished by inoculating anti-interferon-α/β serum before influenza virus infection. No detectable interferon activity was observed in lung and blood of mice inoculated with anti-interferon-α/β serum prior to influenza virus infection. These results suggest that the augmented early interferon production in T-lymphocytes of TDM emulsion-treated mice in response to influenza virus may play an important role in the enhanced resistance.Keywords
This publication has 24 references indexed in Scilit:
- Natural cell-mediated cytotoxicity in rats. II.In vivo augmentation of NK-cell activityInternational Journal of Cancer, 1978
- Influenza virus-induced interferon production in mouse spleen cell culture: T cells as the main producerCellular Immunology, 1977
- Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice.Proceedings of the National Academy of Sciences, 1977
- Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.Proceedings of the National Academy of Sciences, 1977
- BCG-INDUCED MURINE EFFECTOR CELLS .2. CHARACTERIZATION OF NATURAL KILLER CELLS IN PERITONEAL EXUDATES1977
- Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.The Journal of Experimental Medicine, 1976
- Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.The Journal of Experimental Medicine, 1976
- Nonspecific resistance against infection with Salmonella typhi and Salmonella typhimurium induced in mice by cord factor (trehalose-6,6'-dimycolate) and its analoguesInfection and Immunity, 1976
- Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomersBiochemical and Biophysical Research Communications, 1976
- FURTHER IMPROVEMENTS IN PLAQUE TECHNIQUE FOR DETECTING SINGLE ANTIBODY-FORMING CELLS1968